ICD-10 Diagnosis Code Z15.02

Genetic susceptibility to malignant neoplasm of ovary

Diagnosis Code Z15.02

ICD-10: Z15.02
Short Description: Genetic susceptibility to malignant neoplasm of ovary
Long Description: Genetic susceptibility to malignant neoplasm of ovary
This is the 2019 version of the ICD-10-CM diagnosis code Z15.02

Valid for Submission
The code Z15.02 is valid for submission for HIPAA-covered transactions.

Code Classification
  • Factors influencing health status and contact with health services (Z00–Z99)
    • Genetic carrier and genetic susceptibility to disease (Z14-Z15)
      • Genetic susceptibility to disease (Z15)

Information for Medical Professionals


Code Edits
The following edits are applicable to this code:
Diagnoses for females only - Diagnoses for females only.
Unacceptable principal diagnosis - There are selected codes that describe a circumstance which influences an individual’s health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Convert to ICD-9
  • V84.02 - Genetc sus mal neo ovary

Present on Admission (POA)
The code Z15.02 is exempt from POA reporting.

Synonyms
  • Ovarian cancer genetic marker of susceptibility positive

Information for Patients


Ovarian Cancer

The ovaries are part of the female reproductive system. They produce a woman's eggs and female hormones. Each ovary is about the size and shape of an almond.

Cancer of the ovary is not common, but it causes more deaths than other female reproductive cancers. The sooner ovarian cancer is found and treated, the better your chance for recovery. But ovarian cancer is hard to detect early. Women with ovarian cancer may have no symptoms or just mild symptoms until the disease is in an advanced stage. Then it is hard to treat. Symptoms may include

  • A heavy feeling in the pelvis
  • Pain in the lower abdomen
  • Bleeding from the vagina
  • Weight gain or loss
  • Abnormal periods
  • Unexplained back pain that gets worse
  • Gas, nausea, vomiting, or loss of appetite

To diagnose ovarian cancer, doctors do one or more tests. They include a physical exam, a pelvic exam, lab tests, ultrasound, or a biopsy. Treatment is usually surgery followed by chemotherapy.

NIH: National Cancer Institute

  • BRCA1 and BRCA2 gene testing (Medical Encyclopedia)
  • CA-125 blood test (Medical Encyclopedia)
  • Ovarian cancer (Medical Encyclopedia)
  • Ovarian Cancer (Centers for Disease Control and Prevention)
  • Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)

[Read More]

ICD-10 Footnotes

General Equivalence Map Definitions
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

  • Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
  • No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
  • Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.

Present on Admission
The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement.

Previous Code
Z15.01
Next Code
Z15.03